This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (6)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Cerebrovascular Disease  • Cardiovascular System  • Thrombolysis  • Alert me on articles by topic

Arch Neurol. 1998;55:450-451.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

IN THIS issue of the ARCHIVES, Grond et al¹ report favorable results of treatment in 10 of 12 patients with acute vertebrobasilar territory ischemia given intravenous (IV) recombinant tissue-type plasminogen activator followed with heparin. Physicians have sought desperately during the past half century to find an effective treatment for patients with acute brain ischemia. Thrombolytic treatment is clearly au courant but many questions remain. Which thrombolytic drug should be used, at what dosage, given by which route, to which patients, with what vascular lesions, with what time constraints? What extent, if any, of brain infarction, determined by what technology prior to infusion, contraindicates thrombolysis or provides a major risk for its use? What tests are needed before treatment? Should heparin or any other coagulation-modifying agent or angioplasty be used after thrombolysis and when? The report of Grond et al¹ must be viewed in the context of what is already known . . . [Full Text of this Article]

RELATED ARTICLES

Stroke 1998
Roger N. Rosenberg
Arch Neurol. 1998;55(4):448.
EXTRACT | FULL TEXT  

Early Intravenous Thrombolysis With Recombinant Tissue-type Plasminogen Activator in Vertebrobasilar Ischemic Stroke
Martin Grond, Jobst Rudolf, Susanne Schmülling, Christoph Stenzel, Michael Neveling, and Wolf-Dieter Heiss
Arch Neurol. 1998;55(4):466-469.
ABSTRACT | FULL TEXT  

Proximal Extracranial Vertebral Artery Disease in the New England Medical Center Posterior Circulation Registry
Robert J. Wityk, Hui M. Chang, Axel Rosengart, Wen-Chaing Han, L. Dana DeWitt, Michael S. Pessin, and Louis R. Caplan
Arch Neurol. 1998;55(4):470-478.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Stroke 1998
Rosenberg
Arch Neurol 1998;55:448-448.
FULL TEXT